| # | Drug | Count |
|---|---|---|
| 0 | RISEDRONATE SODIUM | 2 |
| 1 | AFLIBERCEPT | 1 |
| 2 | AMLODIPINE | 1 |
| 3 | ASPIRIN | 1 |
| 4 | ASPIRIN 325 MG | 1 |
| 5 | ASPIRIN 81 MG | 1 |
| 6 | BOSENTAN | 1 |
| 7 | BROLUCIZUMAB | 1 |
| 8 | DILTIAZEM HYDROCHLORIDE | 1 |
| 9 | ERENUMAB-AOOE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BROLUCIZUMAB | 1 | 0.0003 |
| 1 | ESOMEPRAZOLE MAGNESIUM DIHYDRATE | 1 | 0.0001 |
| 2 | RISEDRONATE SODIUM | 2 | 0.0001 |
| 3 | LIFITEGRAST | 1 | 0.0001 |
| 4 | ROSUVASTATIN CALCIUM | 1 | 0.0000 |
| 5 | DILTIAZEM HYDROCHLORIDE | 1 | 0.0000 |
| 6 | AFLIBERCEPT | 1 | 0.0000 |
| 7 | ZOLEDRONIC ACID | 1 | 0.0000 |
| 8 | BOSENTAN | 1 | 0.0000 |
| 9 | ERENUMAB-AOOE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 1 | 0.0001 |
| 1 | Phosphodiesterase 5 Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Factor Xa Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Dihydropyridine Calcium Channel Blocker [EPC] | 1 | 0.0000 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Proton Pump Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |